logo
logo

Neonc Technologies, Inc. announced it raised $0 in an amended filing from an offering of $20 Million

Jun 08, 2017about 8 years ago

Amount Raised

$0

CalabasasBiotechnology

Company Information

Company

NeOnc Technologies

Location

23975 PARK SORRENTO

Calabasas, California, United States

About

NeOnc Technologies is a publicly traded, clinical-stage biopharmaceutical company developing innovative therapies for brain and central nervous system cancers. Its lead programs—NEO100-01, NEO100-02, NEO100-03, and NEO212—utilize proprietary formulations to bypass the blood-brain barrier and target malignancies with precision. The company’s IP portfolio includes 176 patents worldwide, reflecting a broad platform with strong commercialization potential.

FundzWatch™ Score

74
Medium Activity

Buyer Intent Analysis

Get personalized insights on buying likelihood

Related People